X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (158) 158
female (122) 122
oncology (106) 106
middle aged (104) 104
male (96) 96
adult (80) 80
aged (74) 74
cancer (58) 58
index medicus (52) 52
chemotherapy (35) 35
aged, 80 and over (32) 32
article (28) 28
breast cancer (23) 23
neoplasm staging (23) 23
treatment outcome (23) 23
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
prognosis (22) 22
retrospective studies (22) 22
radiotherapy (20) 20
surgery (20) 20
animals (19) 19
carcinoma (19) 19
combined modality therapy (18) 18
immunology (18) 18
mice (18) 18
clinical trials (17) 17
immunotherapy (17) 17
research (17) 17
tumors (17) 17
follow-up studies (16) 16
hematology (16) 16
prospective studies (16) 16
toxicity (16) 16
dose-response relationship, drug (15) 15
survival analysis (15) 15
survival rate (14) 14
therapy (14) 14
adolescent (13) 13
breast neoplasms - pathology (13) 13
care and treatment (13) 13
expression (13) 13
medicine, research & experimental (13) 13
melanoma (13) 13
patients (13) 13
time factors (13) 13
hematology, oncology and palliative medicine (12) 12
immunohistochemistry (12) 12
lymphocytes (12) 12
metastasis (12) 12
pharmacology & pharmacy (12) 12
radiation (11) 11
remission induction (11) 11
survival (11) 11
antineoplastic agents - therapeutic use (10) 10
biopsy (10) 10
disease-free survival (10) 10
drug administration schedule (10) 10
neoplasms - drug therapy (10) 10
phase-i (10) 10
radiology, nuclear medicine & medical imaging (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
breast neoplasms - immunology (9) 9
cells (9) 9
dendritic cells - immunology (9) 9
head and neck neoplasms - drug therapy (9) 9
lymphatic metastasis (9) 9
medicine & public health (9) 9
recurrence (9) 9
risk factors (9) 9
t-cells (9) 9
antineoplastic agents - adverse effects (8) 8
breast neoplasms - therapy (8) 8
carcinoma, squamous cell - pathology (8) 8
cell line, tumor (8) 8
lymphocytes t (8) 8
melanoma - pathology (8) 8
metastases (8) 8
oncology, experimental (8) 8
pharmacokinetics (8) 8
phenotype (8) 8
respiratory system (8) 8
squamous-cell carcinoma (8) 8
t-lymphocytes - immunology (8) 8
transplantation (8) 8
vaccination (8) 8
5-fluorouracil (7) 7
apoptosis (7) 7
blood (7) 7
breast neoplasms - drug therapy (7) 7
cancer vaccines - immunology (7) 7
carcinoma, squamous cell - drug therapy (7) 7
chemotherapy, adjuvant (7) 7
cisplatin (7) 7
cisplatin - administration & dosage (7) 7
dendritic cell (7) 7
dendritic cells (7) 7
fluorouracil - administration & dosage (7) 7
gene (7) 7
in-vitro (7) 7
leukopenia - chemically induced (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 04/2015, Volume 520, Issue 7547, pp. 373 - 377
Journal Article
Nature, ISSN 0028-0836, 05/2017, Volume 545, Issue 7652, pp. 60 - 65
Despite the success of monotherapies based on blockade of programmed cell death 1 (PD-1) in human melanoma, most patients do not experience durable clinical... 
CRITERIA | MELANOMA | PEMBROLIZUMAB | IMMUNE CHECKPOINT BLOCKADE | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | BRAF INHIBITORS | CHRONIC VIRAL-INFECTION | CANCER-THERAPY | IPILIMUMAB | EXHAUSTION | CD8-Positive T-Lymphocytes - cytology | Antibodies, Monoclonal, Humanized - therapeutic use | Melanoma - blood supply | Humans | Ki-67 Antigen - metabolism | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Treatment Outcome | Melanoma - pathology | Phenotype | Antibodies, Monoclonal, Humanized - administration & dosage | Ki-67 Antigen - immunology | Antibodies, Monoclonal, Humanized - pharmacokinetics | Melanoma - immunology | Melanoma - drug therapy | CD8-Positive T-Lymphocytes - metabolism | Female | Programmed Cell Death 1 Receptor - immunology | Antibodies, Monoclonal, Humanized - immunology | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | Tumor Burden - immunology | Oncology, Experimental | Melanoma | Physiological aspects | Research | T cells | Tumors | Apoptosis | Cancer | Profiling | PD-1 protein | CD8 antigen | Medical services | Clinical trials | Lymphocytes T | Blood | Metastases | Immunology | Lymphocytes | Immunotherapy | Peripheral blood | Pretreatment | Medical research | Immunoglobulins | T cell receptors | Pharmacology | Patients | Pathology | Cell death | PD-L1 protein | Infiltration
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 2, pp. 135 - 145
Blocking lymphocyte chemotaxis with an oral inhibitor of the CCR5 receptor was associated with reduced incidence of visceral graft-versus-host disease (GVHD)... 
MEDICINE, GENERAL & INTERNAL | HEMATOPOIETIC-CELL TRANSPLANTATION | BONE-MARROW-TRANSPLANTATION | ACUTE GVHD | UNRELATED DONORS | CLINICAL-TRIALS | PREPARATIVE REGIMENS | HEMATOLOGIC MALIGNANCIES | CHEMOKINE RECEPTOR CCR5 | R5 HIV-1 INFECTION | T-CELLS | Hematologic Neoplasms - therapy | T-Lymphocytes - physiology | Triazoles - adverse effects | Cyclohexanes - pharmacology | Humans | Middle Aged | Male | Graft vs Host Disease - immunology | Chemokine CCL3 - antagonists & inhibitors | Chemokine CCL5 - antagonists & inhibitors | Transplantation, Homologous | Young Adult | Cyclohexanes - therapeutic use | Chemotaxis, Leukocyte - drug effects | Graft vs Host Disease - mortality | T-Lymphocytes - drug effects | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Cyclohexanes - adverse effects | CCR5 Receptor Antagonists | Triazoles - therapeutic use | Kaplan-Meier Estimate | Triazoles - pharmacology | Graft vs Host Disease - prevention & control | Aged | Drugs | Dose-response relationship (Biochemistry) | Maraviroc | Lymphocytes | Physiological aspects | Graft versus host reaction | Dosage and administration | Product/Service Evaluations | Research | Drug therapy | Health aspects | Chemokine receptors | Graft-versus-host reaction | CCR5 protein | Transplants & implants | Risk groups | Liver | Prophylaxis | Stem cell transplantation | Lymphocytes T | Chemotaxis | Hemopoiesis | Human immunodeficiency virus--HIV | Internalization | Bone marrow
Journal Article
Annals of Thoracic Surgery, ISSN 0003-4975, 2012, Volume 93, Issue 5, pp. 1658 - 1667
Journal Article
Nature Medicine, ISSN 1078-8956, 03/2019, Volume 25, Issue 3, pp. 454 - 461
Journal Article
Human Pathology, ISSN 0046-8177, 02/2018, Volume 72, pp. 66 - 70
The Notch signaling pathway is integral to normal human development and homeostasis and has a deterministic function on cell differentiation. Recent studies... 
Esophageal squamous cell carcinoma | Overall survival | Notch signaling | Carcinogenesis | Surgical pathology | CHROMOSOMAL TRANSLOCATIONS | GENE | ADENOCARCINOMA | PATHOLOGY | LYMPHOBLASTIC NEOPLASMS | CANCER | Genotype & phenotype | Insects | Stem cells | Metastasis | Gender | Gene expression | Patients | Variance analysis | Age | Esophageal cancer | Quantitative analysis | Tumors
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2009, Volume 4, Issue 8, pp. e6539 - e6539
Journal Article